Illumina, Inc. Files 8-K: Director Departure, New Officer

Ticker: ILMN · Form: 8-K · Filed: Apr 2, 2026 · CIK: 0001110803

Illumina, INC. 8-K Filing Summary
FieldDetail
CompanyIllumina, INC. (ILMN)
Form Type8-K
Filed DateApr 2, 2026
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-appointment, director-departure

Related Tickers: ILMN

TL;DR

Illumina's 8-K shows a director out, a new officer in. Standard filing.

AI Summary

On April 2, 2026, Illumina, Inc. filed an 8-K report detailing the departure of a director and the appointment of a new officer. The filing also includes a Regulation FD disclosure and financial statements/exhibits.

Why It Matters

Changes in key personnel and officer appointments can signal shifts in company strategy or operational focus.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance and disclosure items, not significant financial events.

Key Players & Entities

FAQ

What specific officer was appointed?

The filing indicates the appointment of a certain officer under Item 5.02, but the specific name and title are not detailed in the provided summary information.

Which director departed from Illumina, Inc.?

Item 5.02 of the 8-K filing addresses the departure of a director, but the name of the departing director is not specified in the provided text.

What is the purpose of the Regulation FD Disclosure (Item 7.01)?

The purpose of Item 7.01 is to provide disclosure under Regulation FD, ensuring that material non-public information is broadly disseminated to the public.

What types of exhibits are included with this 8-K filing?

The filing includes exhibits such as a press release (EX-99.1), graphics, and XBRL documents for financial reporting.

What is Illumina, Inc.'s primary business according to the SIC code?

Illumina, Inc.'s primary business is listed under SIC code 3826 as Laboratory Analytical Instruments.

Filing Stats: 672 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2026-04-02 09:09:56

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On April 2, 2026, the Company issued a press release announcing the changes in Board membership described in Item 5.02(b) above and that the Board has nominated David King for election as a director at the Company's 2026 annual meeting of stockholders. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1 , shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Illumina, Inc. Press Release, dated April 2, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ILLUMINA, INC. Date: April 2, 2026 By: /s/ SCOTT DAVIES Name: Scott Davies Title: Chief Legal Officer Exhibit Index Exhibit Number Description 99.1 Illumina, Inc. Press Release, dated April 2, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing